Back to News
Market Impact: 0.25
Baird Upgrades Humana to Outperform from Neutral
Source: Nasdaq
Analyst InsightsHealthcare & Biotech
On October 9, 2026, Baird upgraded its outlook on Humana from Neutral to Outperform. The report provides no price target, rationale, or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
HUM0.55
More News
- Humana Stock Jumps on Raised Medicare Advantage Ratings
- Premarket movers: Humana rallies; SpaceX deal sends telco stocks down
- Baird upgrades Humana stock rating on margin recovery outlook
- Wall St futures gain as oil slips; telecoms pressured by SpaceX spectrum deal
- Gold Rises Over 1%; US Consumer Sentiment Falls
- Stocks making the biggest moves premarket: Delta Air Lines, SpaceX, T-Mobile, Humana & more